A feasibility dosimetric study on prostate cancer (Q60393607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

A feasibility dosimetric study on prostate cancer : are we ready for a multicenter clinical trial on SBRT? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Lidia Strigari

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Pietro Mancosu

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Carmelo Marino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Elena Villaggi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Giulia Maggi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Elisa Bonanno

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Claudia Carbonini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rita Consorti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

David Fedele

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Christian Fiandra

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Isidora Ielo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tiziana Malatesta

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Maria Rosa Malisan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Anna Martinotti

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Renzo Moretti

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Barbara Nardiello

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Caterina Oliviero

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Stefania Clemente

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Giusi R Borzì

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

8 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

573-581

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-015-0822-6

2 March 2020

exact match

0 references

cites work

Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer

1 reference

12 December 2020

Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer

1 reference

12 December 2020

Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review

1 reference

12 December 2020

Biologically effective dose and definitive radiation treatment for localized prostate cancer: treatment gaps do affect the risk of biochemical failure

1 reference

12 December 2020

Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations.

1 reference

12 December 2020

Updated Results and Patterns of Failure in a Randomized Hypofractionation Trial for High-risk Prostate Cancer

1 reference

12 December 2020

Stereotactic body radiotherapy: overview of the 2010 Royal College of Radiologists' annual scientific meeting.

1 reference

12 December 2020

Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical, and pathological outcomes

1 reference

12 December 2020

Systematic review of hypofractionated radiation therapy for prostate cancer

1 reference

12 December 2020

What hypofractionated protocols should be tested for prostate cancer?

1 reference

12 December 2020

Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer

1 reference

12 December 2020

The radiobiology of prostate cancer including new aspects of fractionated radiotherapy

1 reference

12 December 2020

Application of organ tolerance dose-constraints in clinical studies in radiation oncology

1 reference

12 December 2020

The relation between various conformity indices and the influence of the target coverage difference in prescription isodose surface on these values in intracranial stereotactic radiosurgery

1 reference

12 December 2020

Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review

1 reference

12 December 2020

Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT).

1 reference

12 December 2020

Stereotactic body radiotherapy. Guidelines for commissioners, providers and clinicians: a national report

1 reference

12 December 2020

A simple and reliable index for scoring rival stereotactic radiosurgery plans.

1 reference

12 December 2020

Stereotactic body radiotherapy in prostate cancer: is rapidarc a better solution than cyberknife?

1 reference

12 December 2020

New horizons and hurdles for UK radiotherapy: can prostate stereotactic body radiotherapy show the way?

1 reference

12 December 2020

Prostate cancer and the hypofractionation hypothesis

1 reference

12 December 2020

Experimental verification of convolution/superposition photon dose calculations for radiotherapy treatment planning

1 reference

12 December 2020

Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.

1 reference

12 December 2020

Serious complications associated with stereotactic ablative radiotherapy and strategies to mitigate the risk

1 reference

12 December 2020

Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes

1 reference

12 December 2020

Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study

1 reference

12 December 2020

Experience of micromultileaf collimator linear accelerator based single fraction stereotactic radiosurgery: tumor dose inhomogeneity, conformity, and dose fall off

1 reference

12 December 2020

Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?

1 reference

12 December 2020

Stereotactic body radiation therapy: the report of AAPM Task Group 101.

1 reference

12 December 2020

Hypofractionation for prostate cancer: a critical review

1 reference

12 December 2020

Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance

1 reference

12 December 2020

Moderately hypofractionated radiotherapy for localized prostate cancer: long-term outcome using IMRT and volumetric IGRT.

1 reference

12 December 2020

Homogeneity Index: An objective tool for assessment of conformal radiation treatments.

1 reference

12 December 2020

Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator.

1 reference

12 December 2020

10.1007/S00066-015-0822-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25747263%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference